

Fundamental dimension Equity attribute | HXBMLeader $3.290.00% Cap $739.3KP/E -1.3x QuantScore57/100 | BPTHPeer $0.00030.00% Cap $15.09KP/E -0.0x QuantScore36/100 | CNTRFPeer $0.01160.00% Cap $134.5KP/E -2.1x QuantScore36/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
43/100 |
41/100 |
45/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 100/100 | 20/100 | 20/100 |
Growth Revenue / earnings growth & margins | 50/100 | 19/100 | 45/100 |
Sentiment Analyst ratings, targets & revisions | — | 100/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -1.3x | -0.0x | -2.1x |
Forward P/E (next FY) | — | -0.0x | — |
EV / EBITDA (TTM) | 1.0x | -0.3x | -4.8x |
Price / Sales | 0.9x | — | — |
Price / Free Cash Flow | -1.2x | -0.2x | -2.6x |
PEG ratio | -0.01 | -0.00 | 0.29 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | — | 1 / 9 | 2 / 9 |
Altman Z-Score | — | -33221.25 (Distress) | -2818.18 (Distress) |
Total debt / equity | 0.00 | -0.05 | -0.19 |
Quick ratio | 12.2x | 0.0x | 0.0x |
Interest coverage | — | -7.9x | -2.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +0.4% | — | — |
Net income growth YoY | +43.9% | +12.3% | +44.0% |
Gross margin (TTM) | 99.4% | 0.0% | 0.0% |
Operating margin (FY) | -73.8% | — | — |
FCF margin (FY) | -74.5% | — | — |
5. Trailing price performancePrice change over period |
1M return | -34.2% | +50.0% | 0.0% |
3M return | +83.8% | -99.3% | -73.0% |
6M return | +229.0% | -99.5% | -3.3% |
Year to date | +64.5% | -99.5% | -55.1% |
1Y return | -6.0% | -99.6% | -83.4% |
3Y return | -85.9% | -100.0% | -98.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-3.23 -198.2% premium | $-0.4859 -162051.4% premium | $-0.0659 -668.1% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | 100% Buy0% Hold0% Sell | — |